Kay Wilhelm
Research Subjects
Research Interests
Kay Wilhelm has a total of 275 co-authors. Here are the top co-authors by number of shared publications:
- Gordon Parker
University of New South Wales
15 shared publications - Judith Proudfoot
Black Dog Institute Randwick Australia
13 shared publications - Janine Clarke
Black Dog Inst, Hosp Rd, Randwick, NSW 2031, Australia
9 shared publications - Lesley Campbell
Diabetes and Metabolism Division, Garvan Institute of Medical Research, Sydney, Australia
9 shared publications - Dusan Hadzi-Pavlovic
Affiliation Discipline of Psychiatry and Mental Health, School of Clinical Medicine, UNSW, Sydney, Australia
8 shared publications - Philip Bowden Mitchell
University of New South Wales
8 shared publications
Latest Publications
- Open Access
- 15 October 2025
- Published by Wiley in Australian and New Zealand Journal of Family Therapy
- Vol. 46 (4)
Climate Change and Mental Health: Systems Models for Understanding and Responding
This paper examines systems models proposed for climate change and mental health through a systematic review of the evidence using the Preferred Reporting Items for Systematic Reviews and Meta method and feedback from an Indigenous Elder, knowledge bearer and co‐author (Aunty Rhonda Dixon‐Grovenor). While published systems models of climate change and mental health are relatively recent, markedly increasing since 2020, Indigenous cultural knowledge that exists for thousands of years helps understand the interconnectedness and interdependence of human mental health and nature. Systems modelling of climate change and mental health better reflects the complex interactions between climate change impacts on mental health and provides windows into ways to improve human mental health at individual, family, community and broader societal levels. We present a non‐Indigenous systems model showing direct, indirect, physical health and awareness aspects of climate change impacts on mental health. Using a systems model approach can identify the various levels at which interventions could be considered. Specific examples of using systems models to find solutions for extreme heat are outlined in tables. The potential to improve human mental health using systems modelling to understand climate change and mental health interactions can be enhanced by collaboration and learning together with Indigenous knowledge bearers. In contrast, the failure of the government and companies to value and include the scientific knowledge from Indigenous peoples as solutions to the climate and nature crises means ignoring answers to the greatest threat to human health in this century.
- 15 October 2025
- Published by Wiley in Australian and New Zealand Journal of Family Therapy
- Vol. 46 (4)
Open AccessClimate Change and Mental Health: Systems Models for Understanding and Responding
This paper examines systems models proposed for climate change and mental health through a systematic review of the evidence using the Preferred Reporting Items for Systematic Reviews and Meta method and feedback from an Indigenous Elder, knowledge bearer and co‐author (Aunty Rhonda Dixon‐Grovenor). While published systems models of climate change and mental health are relatively recent, markedly increasing since 2020, Indigenous cultural knowledge that exists for thousands of years helps understand the interconnectedness and interdependence of human mental health and nature. Systems modelling of climate change and mental health better reflects the complex interactions between climate change impacts on mental health and provides windows into ways to improve human mental health at individual, family, community and broader societal levels. We present a non‐Indigenous systems model showing direct, indirect, physical health and awareness aspects of climate change impacts on mental health. Using a systems model approach can identify the various levels at which interventions could be considered. Specific examples of using systems models to find solutions for extreme heat are outlined in tables. The potential to improve human mental health using systems modelling to understand climate change and mental health interactions can be enhanced by collaboration and learning together with Indigenous knowledge bearers. In contrast, the failure of the government and companies to value and include the scientific knowledge from Indigenous peoples as solutions to the climate and nature crises means ignoring answers to the greatest threat to human health in this century.
- 25 July 2023
- Published by SAGE Publications in Australasian Psychiatry
- Vol. 31 (5) , 685-689
The What and the How: A pilot study of feedback from service providers and consumers about service development in new urban mental health hub
Objective: An inner-city hospital purchased a local hotel to provide support, digital engagement, skill development groups and referrals to partner agencies. Being aware of the hotel’s importance to the local community, we sought feedback on a model of care relevant to perceived gaps and needs in support for mental health. Methods: Four online focus groups included healthcare professionals, nominated opinion leaders from local Non-Government Organisations (NGOs), consumers and carers to reflect a range of views. Focus group data were qualitatively analysed. Results: Participants made useful suggestions about WHAT educational, preventative and therapeutic services were needed. They emphasised the importance of HOW people engage with the service, the balance between accessibility and security. Other themes included targeting people with limited health literacy, integration with existing services, building on site heritage and ongoing evaluation of objectives and needs. Conclusions: This pilot study demonstrated clear support for providing safe and welcoming access to services, with resources and access to services to improve their health and wellbeing built on principles of social justice and inclusion. Participants had constructive ideas of what was needed, and ongoing patient and public research is anticipated.
- 25 July 2023
- Published by SAGE Publications in Australasian Psychiatry
- Vol. 31 (5) , 685-689
The What and the How: A pilot study of feedback from service providers and consumers about service development in new urban mental health hub
Objective: An inner-city hospital purchased a local hotel to provide support, digital engagement, skill development groups and referrals to partner agencies. Being aware of the hotel’s importance to the local community, we sought feedback on a model of care relevant to perceived gaps and needs in support for mental health. Methods: Four online focus groups included healthcare professionals, nominated opinion leaders from local Non-Government Organisations (NGOs), consumers and carers to reflect a range of views. Focus group data were qualitatively analysed. Results: Participants made useful suggestions about WHAT educational, preventative and therapeutic services were needed. They emphasised the importance of HOW people engage with the service, the balance between accessibility and security. Other themes included targeting people with limited health literacy, integration with existing services, building on site heritage and ongoing evaluation of objectives and needs. Conclusions: This pilot study demonstrated clear support for providing safe and welcoming access to services, with resources and access to services to improve their health and wellbeing built on principles of social justice and inclusion. Participants had constructive ideas of what was needed, and ongoing patient and public research is anticipated.
- Open Access
- 15 April 2022
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 6 (4) , e28135
The Quality of Internet Websites for People Experiencing Psychosis: Pilot Expert Assessment
Background: Clinicians need to be able to assess the quality of the available information to aid clinical decision-making. The internet has become an important source of health information for consumers and their families. Objective: This study aimed to rate the quality of websites with psychosis-related information (to provide clinicians with a basis for recommending material to guide clinical decision-making with consumers and their families), using a validated instrument as well as a purpose-developed checklist, and consider improvement in quality over a 4-year period. Methods: Two measures of website quality were used: the DISCERN scale and the Psychosis Website Quality Checklist (PWQC). Terms related to psychosis, including “psychotic,” “psychosis,” “schizophrenia,” “delusion,” and “hallucination,” were entered into Google, and the first 25 results were analyzed. In total, 6 raters with varying health professional backgrounds were used to evaluate the websites across two time points: January-March 2014 and January-March 2018. Results: Of the 25 websites rated, only the 6 highest ranked websites achieved a DISCERN score, indicating that they were of “good” quality (51-62 out of a possible 75), while the mean score of the websites (mean 43.96, SD 12.08) indicated an overall “fair” quality. The PWQC revealed that websites scored highly on “availability and usability” (mean 16.82, SD 3.96) but poorly on “credibility” (mean 20.99, SD 6.68), “currency” (mean 5.16, SD 2.62), and “breadth and accuracy” (mean 77.87, SD 23.20). Most sites lacked information about early intervention, recreational drug use and suicide risk, with little change in content over time. Stating an editorial or review process on the website (found in 56% of websites) was significantly associated with a higher quality score on both scales (the DISCERN scale, P=.002; the PWQC, P=.006). Conclusions: The information on the internet available for clinicians to recommend to people affected by psychosis tended to be of “fair” quality. While higher-quality websites exist, it is generally not easy way to assess this on face value. Evidence of an editorial or review process was one indicator of website quality. While sites generally provided basic clinical information, most lacked material addressing weighing up risks and benefits of medication and alternatives, the role of coercive treatment and other more contentious issues. Insufficient emphasis is placed on detailed information on early intervention and importance of lifestyle modifications or how families and friends can contribute. These are likely to be the very answers that consumers and carers are seeking and this gap contributes to unmet needs among this group. We suggest that clinicians should be aware of what is available and where there are gaps.
- 15 April 2022
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 6 (4) , e28135
Open AccessThe Quality of Internet Websites for People Experiencing Psychosis: Pilot Expert Assessment
Background: Clinicians need to be able to assess the quality of the available information to aid clinical decision-making. The internet has become an important source of health information for consumers and their families. Objective: This study aimed to rate the quality of websites with psychosis-related information (to provide clinicians with a basis for recommending material to guide clinical decision-making with consumers and their families), using a validated instrument as well as a purpose-developed checklist, and consider improvement in quality over a 4-year period. Methods: Two measures of website quality were used: the DISCERN scale and the Psychosis Website Quality Checklist (PWQC). Terms related to psychosis, including “psychotic,” “psychosis,” “schizophrenia,” “delusion,” and “hallucination,” were entered into Google, and the first 25 results were analyzed. In total, 6 raters with varying health professional backgrounds were used to evaluate the websites across two time points: January-March 2014 and January-March 2018. Results: Of the 25 websites rated, only the 6 highest ranked websites achieved a DISCERN score, indicating that they were of “good” quality (51-62 out of a possible 75), while the mean score of the websites (mean 43.96, SD 12.08) indicated an overall “fair” quality. The PWQC revealed that websites scored highly on “availability and usability” (mean 16.82, SD 3.96) but poorly on “credibility” (mean 20.99, SD 6.68), “currency” (mean 5.16, SD 2.62), and “breadth and accuracy” (mean 77.87, SD 23.20). Most sites lacked information about early intervention, recreational drug use and suicide risk, with little change in content over time. Stating an editorial or review process on the website (found in 56% of websites) was significantly associated with a higher quality score on both scales (the DISCERN scale, P=.002; the PWQC, P=.006). Conclusions: The information on the internet available for clinicians to recommend to people affected by psychosis tended to be of “fair” quality. While higher-quality websites exist, it is generally not easy way to assess this on face value. Evidence of an editorial or review process was one indicator of website quality. While sites generally provided basic clinical information, most lacked material addressing weighing up risks and benefits of medication and alternatives, the role of coercive treatment and other more contentious issues. Insufficient emphasis is placed on detailed information on early intervention and importance of lifestyle modifications or how families and friends can contribute. These are likely to be the very answers that consumers and carers are seeking and this gap contributes to unmet needs among this group. We suggest that clinicians should be aware of what is available and where there are gaps.
- 19 February 2022
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 41 (6) , 829-839
Impact of frailty on mortality and morbidity in bridge to transplant recipients of contemporary durable mechanical circulatory support
- 19 February 2022
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 41 (6) , 829-839
Impact of frailty on mortality and morbidity in bridge to transplant recipients of contemporary durable mechanical circulatory support
- 6 September 2021
- Published by SAGE Publications in Australasian Psychiatry
- Vol. 29 (6) , 600-603
The effectiveness of a short-term DBT skills group in a ‘real-world’ clinical setting
Objective: This study evaluated the effectiveness of a short-term outpatient DBT (DBT-S) skills group for individuals experiencing pervasive emotion dysregulation (PED). Method: Pre-and post-group outcome data consisted of self-report measures and six-month Mental Health admissions and Emergency Department presentations. Results: Group completers reported significant improvements in psychological distress, depression, borderline symptomatology and functional impairment, increases in ‘skills use’ and decreases in ‘dysfunctional coping’, associated with symptomatic improvement. There were reduced numbers of Mental Health presentations and admissions between six months pre- and post-group. Conclusion: Findings support emerging evidence for DBT-S as an effective, viable treatment for PED.
- 6 September 2021
- Published by SAGE Publications in Australasian Psychiatry
- Vol. 29 (6) , 600-603
The effectiveness of a short-term DBT skills group in a ‘real-world’ clinical setting
Objective: This study evaluated the effectiveness of a short-term outpatient DBT (DBT-S) skills group for individuals experiencing pervasive emotion dysregulation (PED). Method: Pre-and post-group outcome data consisted of self-report measures and six-month Mental Health admissions and Emergency Department presentations. Results: Group completers reported significant improvements in psychological distress, depression, borderline symptomatology and functional impairment, increases in ‘skills use’ and decreases in ‘dysfunctional coping’, associated with symptomatic improvement. There were reduced numbers of Mental Health presentations and admissions between six months pre- and post-group. Conclusion: Findings support emerging evidence for DBT-S as an effective, viable treatment for PED.
- Open Access
Sertraline hydrochloride for reducing impulsive behaviour in male, repeat-violent offenders (ReINVEST): protocol for a phase IV, double-blind, placebo-controlled, randomised clinical trial
Introduction Considerable evidence supports an association between poor impulse control (impulsivity) and violent crime. Furthermore, impulsivity and aggression has been associated with reduced levels of serotonergic activity in the brain. Selective serotonin reuptake inhibitors (SSRIs) are a class of antidepressants that aim to regulate brain serotonin concentrations. Several small studies in psychiatric populations have administered SSRIs to impulsive–aggressive individuals, resulting in reduced impulsivity, anger, aggression and depression. However, no clinical trial has been undertaken in a criminal justice population. This protocol describes the design and implementation of the first systematic study of the potential benefits of SSRIs in impulsive–violent offenders who are at high risk of reoffending. Methods and analysis A randomised, double-blinded, multicentre trial to test the clinical efficacy of an SSRI, sertraline hydrochloride, compared with placebo on recidivism and behavioural measures (including impulsivity, anger, aggression, depression and self-reported offending) over 12 months. 460 participants with histories of violence and screening positive for impulsivity are recruited at several local courts and correctional service offices in New South Wales, Australia. Ethics and dissemination Results will be submitted for publication in a peer-reviewed journal. Possible implications of the effectiveness of this pharmacological intervention include economic benefits of reducing prison costs and societal benefits of improving safety. This study has received ethical approval from the University of New South Wales, Aboriginal Health & Medical Research Council, Corrective Services NSW and the NSW Justice Health and Forensic Mental Health Network. Trial registration number ACTRN12613000442707.
Open AccessSertraline hydrochloride for reducing impulsive behaviour in male, repeat-violent offenders (ReINVEST): protocol for a phase IV, double-blind, placebo-controlled, randomised clinical trial
Introduction Considerable evidence supports an association between poor impulse control (impulsivity) and violent crime. Furthermore, impulsivity and aggression has been associated with reduced levels of serotonergic activity in the brain. Selective serotonin reuptake inhibitors (SSRIs) are a class of antidepressants that aim to regulate brain serotonin concentrations. Several small studies in psychiatric populations have administered SSRIs to impulsive–aggressive individuals, resulting in reduced impulsivity, anger, aggression and depression. However, no clinical trial has been undertaken in a criminal justice population. This protocol describes the design and implementation of the first systematic study of the potential benefits of SSRIs in impulsive–violent offenders who are at high risk of reoffending. Methods and analysis A randomised, double-blinded, multicentre trial to test the clinical efficacy of an SSRI, sertraline hydrochloride, compared with placebo on recidivism and behavioural measures (including impulsivity, anger, aggression, depression and self-reported offending) over 12 months. 460 participants with histories of violence and screening positive for impulsivity are recruited at several local courts and correctional service offices in New South Wales, Australia. Ethics and dissemination Results will be submitted for publication in a peer-reviewed journal. Possible implications of the effectiveness of this pharmacological intervention include economic benefits of reducing prison costs and societal benefits of improving safety. This study has received ethical approval from the University of New South Wales, Aboriginal Health & Medical Research Council, Corrective Services NSW and the NSW Justice Health and Forensic Mental Health Network. Trial registration number ACTRN12613000442707.
- Open Access
- 3 March 2021
- Published by Wiley in Medical Journal of Australia
- Vol. 214 (6) , 279-280
Persistent symptoms up to four months after community and hospital‐managed SARS‐CoV‐2 infection
Click on the article title to read more.
- 3 March 2021
- Published by Wiley in Medical Journal of Australia
- Vol. 214 (6) , 279-280
Open AccessPersistent symptoms up to four months after community and hospital‐managed SARS‐CoV‐2 infection
Click on the article title to read more.
- Open Access
- 23 February 2021
- Published by JMIR Publications Inc. in JMIR Preprints
The Quality of Internet Websites for People Experiencing Psychosis: Pilot Expert Assessment (Preprint)
BACKGROUND Clinicians need to be able to assess the quality of the available information to aid clinical decision-making. The internet has become an important source of health information for consumers and their families. OBJECTIVE This study aimed to rate the quality of websites with psychosis-related information (to provide clinicians with a basis for recommending material to guide clinical decision-making with consumers and their families), using a validated instrument as well as a purpose-developed checklist, and consider improvement in quality over a 4-year period. METHODS Two measures of website quality were used: the DISCERN scale and the Psychosis Website Quality Checklist (PWQC). Terms related to psychosis, including “psychotic,” “psychosis,” “schizophrenia,” “delusion,” and “hallucination,” were entered into Google, and the first 25 results were analyzed. In total, 6 raters with varying health professional backgrounds were used to evaluate the websites across two time points: January-March 2014 and January-March 2018. RESULTS Of the 25 websites rated, only the 6 highest ranked websites achieved a DISCERN score, indicating that they were of “good” quality (51-62 out of a possible 75), while the mean score of the websites (mean 43.96, SD 12.08) indicated an overall “fair” quality. The PWQC revealed that websites scored highly on “availability and usability” (mean 16.82, SD 3.96) but poorly on “credibility” (mean 20.99, SD 6.68), “currency” (mean 5.16, SD 2.62), and “breadth and accuracy” (mean 77.87, SD 23.20). Most sites lacked information about early intervention, recreational drug use and suicide risk, with little change in content over time. Stating an editorial or review process on the website (found in 56% of websites) was significantly associated with a higher quality score on both scales (the DISCERN scale, P=.002; the PWQC, P=.006). CONCLUSIONS The information on the internet available for clinicians to recommend to people affected by psychosis tended to be of “fair” quality. While higher-quality websites exist, it is generally not easy way to assess this on face value. Evidence of an editorial or review process was one indicator of website quality. While sites generally provided basic clinical information, most lacked material addressing weighing up risks and benefits of medication and alternatives, the role of coercive treatment and other more contentious issues. Insufficient emphasis is placed on detailed information on early intervention and importance of lifestyle modifications or how families and friends can contribute. These are likely to be the very answers that consumers and carers are seeking and this gap contributes to unmet needs among this group. We suggest that clinicians should be aware of what is available and where there are gaps.
- 23 February 2021
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessThe Quality of Internet Websites for People Experiencing Psychosis: Pilot Expert Assessment (Preprint)
BACKGROUND Clinicians need to be able to assess the quality of the available information to aid clinical decision-making. The internet has become an important source of health information for consumers and their families. OBJECTIVE This study aimed to rate the quality of websites with psychosis-related information (to provide clinicians with a basis for recommending material to guide clinical decision-making with consumers and their families), using a validated instrument as well as a purpose-developed checklist, and consider improvement in quality over a 4-year period. METHODS Two measures of website quality were used: the DISCERN scale and the Psychosis Website Quality Checklist (PWQC). Terms related to psychosis, including “psychotic,” “psychosis,” “schizophrenia,” “delusion,” and “hallucination,” were entered into Google, and the first 25 results were analyzed. In total, 6 raters with varying health professional backgrounds were used to evaluate the websites across two time points: January-March 2014 and January-March 2018. RESULTS Of the 25 websites rated, only the 6 highest ranked websites achieved a DISCERN score, indicating that they were of “good” quality (51-62 out of a possible 75), while the mean score of the websites (mean 43.96, SD 12.08) indicated an overall “fair” quality. The PWQC revealed that websites scored highly on “availability and usability” (mean 16.82, SD 3.96) but poorly on “credibility” (mean 20.99, SD 6.68), “currency” (mean 5.16, SD 2.62), and “breadth and accuracy” (mean 77.87, SD 23.20). Most sites lacked information about early intervention, recreational drug use and suicide risk, with little change in content over time. Stating an editorial or review process on the website (found in 56% of websites) was significantly associated with a higher quality score on both scales (the DISCERN scale, P=.002; the PWQC, P=.006). CONCLUSIONS The information on the internet available for clinicians to recommend to people affected by psychosis tended to be of “fair” quality. While higher-quality websites exist, it is generally not easy way to assess this on face value. Evidence of an editorial or review process was one indicator of website quality. While sites generally provided basic clinical information, most lacked material addressing weighing up risks and benefits of medication and alternatives, the role of coercive treatment and other more contentious issues. Insufficient emphasis is placed on detailed information on early intervention and importance of lifestyle modifications or how families and friends can contribute. These are likely to be the very answers that consumers and carers are seeking and this gap contributes to unmet needs among this group. We suggest that clinicians should be aware of what is available and where there are gaps.
- Open Access
- 1 December 2020
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 22 (12) , e16729
A Web-Based Mental Health Intervention to Improve Social and Occupational Functioning in Adults With Type 2 Diabetes (The Springboard Trial): 12-Month Outcomes of a Randomized Controlled Trial
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: People with type 2 diabetes often experience mental health symptoms that impair functioning, exacerbate illness and increase mortality risk. Access to psychological support is typically low in people with type 2 diabetes. Detection of depression is variable in the primary care setting and can be further impacted by the stigma attached to mental health conditions. Electronic mental health (eMH) programs may provide an accessible, private, non-stigmatising mental health solution for this group. Objective: To evaluate the efficacy of an eMH program (myCompass) for improving social and occupational functioning in a community sample of people with type 2 diabetes and self-reported mild-to-moderate depressive symptoms. myCompass is a fully-automated and self-guided online public health program for people with depression and/or anxiety. The effects of myCompass on depressive symptoms, diabetes-related distress, anxiety symptoms and self-care behaviour were also examined. Methods: Adults with type 2 diabetes and mild-to-moderate depressive symptoms (n = 780) were recruited via online advertisements, community organisations and general practices. Screening, consent and self-report questionnaires were administered online. Eligible participants were randomised to receive either myCompass (n = 391) for 8 weeks plus a 4-week tailing off period, or an active attention control (n = 379). At baseline and at 3-, 6-, and 12-months post-intervention, participants completed the Work and Social Adjustment Scale (WSAS), the Patient Health Questionnaire-9 item (PHQ-9), Diabetes Distress Scale (DDS), Generalised Anxiety Disorder Questionnaire-7 item (GAD-7) and items from the Self-Management Profile for Type 2 Diabetes (SMP-T2D). Glycosylated haemoglobin (HbA1c) measures were obtained at baseline, 6- and 12-months post-intervention. Results: myCompass users logged-in an average of six times and completed an average of .29 modules. Healthy Lifestyles users logged-in an average of four times and completed an average of 1.37 modules. At baseline, mean scores on several outcome measures, including the primary outcome of work and social functioning, were near to the normal range, despite a varied and extensive recruitment process. Of the 780 trial participants, 304 (39%) completed all post-intervention assessments. Intention-to-treat analyses revealed slightly greater improvement in work and social functioning for the Healthy Lifestyles group relative to the myCompass group. All participants reported equivalent improvements in depression anxiety, diabetes distress, diabetes self-management and glycaemic control across the trial. Conclusions: The Healthy Lifestyles group reported higher ratings of social and occupational functioning than the myCompass group, but no differences were observed for any secondary outcome. Although these findings should be interpreted in light of the near-floor symptom scores at baseline, the trial yields insights into mental health research in the context of T2DM, particularly the issues of engagement with programs which focus specifically on mental health. Several avenues emerge for continued investigation into how best to deal with the growing mental health burden in adults with T2DM. Clinical Trial: ACTRN12615000931572
- 1 December 2020
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 22 (12) , e16729
Open AccessA Web-Based Mental Health Intervention to Improve Social and Occupational Functioning in Adults With Type 2 Diabetes (The Springboard Trial): 12-Month Outcomes of a Randomized Controlled Trial
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: People with type 2 diabetes often experience mental health symptoms that impair functioning, exacerbate illness and increase mortality risk. Access to psychological support is typically low in people with type 2 diabetes. Detection of depression is variable in the primary care setting and can be further impacted by the stigma attached to mental health conditions. Electronic mental health (eMH) programs may provide an accessible, private, non-stigmatising mental health solution for this group. Objective: To evaluate the efficacy of an eMH program (myCompass) for improving social and occupational functioning in a community sample of people with type 2 diabetes and self-reported mild-to-moderate depressive symptoms. myCompass is a fully-automated and self-guided online public health program for people with depression and/or anxiety. The effects of myCompass on depressive symptoms, diabetes-related distress, anxiety symptoms and self-care behaviour were also examined. Methods: Adults with type 2 diabetes and mild-to-moderate depressive symptoms (n = 780) were recruited via online advertisements, community organisations and general practices. Screening, consent and self-report questionnaires were administered online. Eligible participants were randomised to receive either myCompass (n = 391) for 8 weeks plus a 4-week tailing off period, or an active attention control (n = 379). At baseline and at 3-, 6-, and 12-months post-intervention, participants completed the Work and Social Adjustment Scale (WSAS), the Patient Health Questionnaire-9 item (PHQ-9), Diabetes Distress Scale (DDS), Generalised Anxiety Disorder Questionnaire-7 item (GAD-7) and items from the Self-Management Profile for Type 2 Diabetes (SMP-T2D). Glycosylated haemoglobin (HbA1c) measures were obtained at baseline, 6- and 12-months post-intervention. Results: myCompass users logged-in an average of six times and completed an average of .29 modules. Healthy Lifestyles users logged-in an average of four times and completed an average of 1.37 modules. At baseline, mean scores on several outcome measures, including the primary outcome of work and social functioning, were near to the normal range, despite a varied and extensive recruitment process. Of the 780 trial participants, 304 (39%) completed all post-intervention assessments. Intention-to-treat analyses revealed slightly greater improvement in work and social functioning for the Healthy Lifestyles group relative to the myCompass group. All participants reported equivalent improvements in depression anxiety, diabetes distress, diabetes self-management and glycaemic control across the trial. Conclusions: The Healthy Lifestyles group reported higher ratings of social and occupational functioning than the myCompass group, but no differences were observed for any secondary outcome. Although these findings should be interpreted in light of the near-floor symptom scores at baseline, the trial yields insights into mental health research in the context of T2DM, particularly the issues of engagement with programs which focus specifically on mental health. Several avenues emerge for continued investigation into how best to deal with the growing mental health burden in adults with T2DM. Clinical Trial: ACTRN12615000931572
- Open Access
- 25 November 2020
- Published by Springer Nature in BMC Psychiatry
- Vol. 20 (1) , 1-8
Should we increase the focus on diet when considering associations between lifestyle habits and deliberate self-harm?
Background: Despite increasing awareness of high rates of physical illness and poor lifestyle behaviours among patients with a history of repeated deliberate self-harm (DSH), there is little research on specific lifestyle factors that are potentially problematic for this group. This paper aims to explore the relationship between lifetime repeated DSH and certain lifestyle factors, including balanced meals, eating breakfast, consumption of ‘junk’ food, weight, exercise, substance/alcohol use, smoking and social support, in a cohort of patients who presented to the Emergency Department (ED) with suicidal ideation or DSH. Methods: From 2007 to 2016, data from lifestyle and mental health measures were collected from 448 attenders at an outpatient clinic for DSH or suicidal ideation following ED presentation. Lifestyle behaviours (Fantastic Lifestyle Checklist) and mental health (Depression and Anxiety Stress Scale), clinical diagnosis and number of previous DSH episodes were measured on arrival. The associations between lifestyle variables and the number of lifetime DSH episodes were examined. Results: Sex, age, depression symptoms, poor diet, and smoking were all associated with a higher average number of deliberate self-harm episodes across the lifespan. There were non-significant positive trends for the other poor lifestyle behaviours. There was no association between DSH episodes and diagnosis of depression or anxiety disorder. In a multiple linear regression model, the only factors that remained significant were age, smoking and eating balanced meals, however, the relationship between smoking and lifetime DSH was moderated by more immediate DSH behaviours. Conclusion: In this sample of patients referred to a service following presentation to the ED with acute mental health concerns, balanced meals and smoking were the lifestyle behaviours that were found to have the strongest independent association with repeated DSH across the lifespan.
- 25 November 2020
- Published by Springer Nature in BMC Psychiatry
- Vol. 20 (1) , 1-8
Open AccessShould we increase the focus on diet when considering associations between lifestyle habits and deliberate self-harm?
Background: Despite increasing awareness of high rates of physical illness and poor lifestyle behaviours among patients with a history of repeated deliberate self-harm (DSH), there is little research on specific lifestyle factors that are potentially problematic for this group. This paper aims to explore the relationship between lifetime repeated DSH and certain lifestyle factors, including balanced meals, eating breakfast, consumption of ‘junk’ food, weight, exercise, substance/alcohol use, smoking and social support, in a cohort of patients who presented to the Emergency Department (ED) with suicidal ideation or DSH. Methods: From 2007 to 2016, data from lifestyle and mental health measures were collected from 448 attenders at an outpatient clinic for DSH or suicidal ideation following ED presentation. Lifestyle behaviours (Fantastic Lifestyle Checklist) and mental health (Depression and Anxiety Stress Scale), clinical diagnosis and number of previous DSH episodes were measured on arrival. The associations between lifestyle variables and the number of lifetime DSH episodes were examined. Results: Sex, age, depression symptoms, poor diet, and smoking were all associated with a higher average number of deliberate self-harm episodes across the lifespan. There were non-significant positive trends for the other poor lifestyle behaviours. There was no association between DSH episodes and diagnosis of depression or anxiety disorder. In a multiple linear regression model, the only factors that remained significant were age, smoking and eating balanced meals, however, the relationship between smoking and lifetime DSH was moderated by more immediate DSH behaviours. Conclusion: In this sample of patients referred to a service following presentation to the ED with acute mental health concerns, balanced meals and smoking were the lifestyle behaviours that were found to have the strongest independent association with repeated DSH across the lifespan.